The pooled analysis demonstrated a significant association between elevated β2M levels and poor OS in DLBCL patients (HR Pooled: 1.65, 95% CI: 1.45–1.88, p‐value < 0.01). The gene discussed is B2M; the disease is diffuse large B-cell lymphoma.